HOME >> MEDICINE >> NEWS
Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs

Two new review studies evaluating the safety of the pain-relieving medications selective cyclooxygenase 2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) find increased cardiovascular and kidney risks. The studies and an accompanying editorial were posted online today by JAMA because of the public health implications of the findings. The articles will appear in the October 4 print issue of JAMA.

"It is estimated that more than 30 million people worldwide take nonsteroidal anti-inflammatory drugs (NSAIDs) daily for treatment of pain and inflammation," according to background information provided in one of the articles. Adverse effects of some conventional NSAIDs include toxic gastrointestinal (GI) effects, as well as adverse renal (kidney) effects. "Overall, an estimated 2.5 million individuals in the United States annually experience adverse renal effects caused by use of NSAIDs," the authors write. "With decreased risk of adverse GI effects, a class of drugs that selectively inhibits COX-2 enzyme was introduced for analgesia (pain relief) and the treatment of arthritis." According to the authors, the adverse renal effects of selective COX-2 inhibition are unclear. Evidence is accumulating on the potential class effect of COX-2 inhibitors on cardiovascular risk. Two COX-2 inhibitors have already been withdrawn from the market: rofecoxib (marketed as Vioxx) and valdecoxib (marketed as Bextra).

Jingjing Zhang, M.D., Ph.D., from Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues evaluated the adverse risks of renal events and arrhythmia (disturbance of the normal heart rhythm) events in patients prescribed COX-2 inhibitors from a systematic review of the medical literature to determine if these negative side-effects involve every drug in this class.

"In this comprehensive meta-analysis of 114 randomized trials of COX-2 inhibitors comprised of 116,094 participants, rofecoxi
'"/>

Contact: Todd Datz
617-432-3952
JAMA and Archives Journals
12-Sep-2006


Page: 1 2 3 4 5

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... ... February 13, 2019 , ... Following the longest federal government ... American Academy of Sleep Medicine (AASM) is warning that such shutdowns exacerbate the ... Transportation Security Administration (TSA) officers. , “Even in typical circumstances, safety may be ...
(Date:2/13/2019)... , ... February 13, 2019 , ... ... 2019, at the company’s annual member conference, Elevate 2019 at the Gaylord Rockies ... staff and members to explore potential partnerships driving improved quality of patient care, ...
(Date:2/13/2019)... ... ... Castle announced today that it has raised $9.2M in Series A funding ... First Round and F-Prime Capital Partners . Angel investors joining the ... Alto Networks, and Olivier Pomel, CEO at Datadog. This round brings the company’s total ...
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Jig Patel and the ... Merchant, an exceptionally talented and knowledgeable dentist from St. Louis, MO, to ... techniques, such as CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, Dr. ...
(Date:2/13/2019)... ... 2019 , ... Surgery that moves both jaws forward – known as maxillomandibular ... (OSA), resulting in benefits that include improved breathing, daytime wakefulness and quality of life, ... should be regarded as the preferred treatment for patients with moderate to severe OSA ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... February 13, 2019 , ... The Louisville Men’s Clinic has ... of 2013 and, to date, has been visited by over 20,000 men suffering ... 90% success rate, The Louisville Men’s Clinic prides itself on being on the ...
(Date:2/13/2019)... , ... February 13, 2019 , ... ... innovation expert, will deliver the keynote speech on Wednesday, May 8, at its ... May 6-8 at the Westin Kierland Resort & Spa in Scottsdale, Arizona, and ...
(Date:2/13/2019)... ... February 13, 2019 , ... IMAT Solutions, a ... is launching IMAT 8.0, its latest health data platform, at HIMSS 2019. , ... interface and dynamic single-query builder, IMAT 8.0 allows HIEs, payers, hospitals, clinics, and ...
Breaking Medicine Technology:
Cached News: